Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease

Journal of Neuroimaging

Volumn 26, Issue 2, 2016, Pages 207-212

  Verclytte, Sebastien ^a,b   Lopes, Renaud ^d   Lenfant, Pierre ^c   Rollin, Adeline ^c   Semah, Franck ^c   Leclerc, Xavier ^c,d   Pasquier, Florence ^c   Delmaire, Christine ^c,d  

^a UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^b Centre Hospitalier Saint Philibert GHICL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIV LILLE   (France)

Author keywords

Alzheimer's disease; Arterial spin labeling; Dementia; Early onset Alzheimer's disease; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SPIN LABEL;

ADULT; ALZHEIMER DISEASE; ARTERIAL SPIN LABELING MAGNETIC RESONANCE IMAGING; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; EARLY ONSET ALZHEIMER DISEASE; FEMALE; FRONTAL LOBE; GLUCOSE METABOLISM; HUMAN; INFERIOR PARIETAL LOBULE; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL CORTEX; PARIETAL LOBE; PERFUSION WEIGHTED IMAGING; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX; BRAIN; BRAIN CIRCULATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SPIN LABELS;

EID: 84959181471     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12264     Document Type: Article

References (47)

1. Bohnen NI, Djang DS, Herholz K, et al. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 2012;53:59-71.
2. Filippi M, Agosta F, Barkhof F, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012;19:e131-40, 1487-501.
3. Ishii K. PET Approaches for diagnosis of dementia. Am J Neuroradiol 2014;35:2030-8.
4. Mosconi L, Tsui WH, Herholz K, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 2008;49:390-8.
5. Scheltens P. Early diagnosis of dementia: neuroimaging. J Neurol 1999;246:16-20.
6. Fox NC, Crum WR, Scahill RI, et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 2001;358:201-5.
7. Jack CR Jr, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591-600.
8. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996;119(Pt 6):2001-7.
9. Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A 2002;99:4703-7.
10. Chen Y, Wolk DA, Reddin JS, et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 2011;77:1977-85.
11. Musiek ES, Chen Y, Korczykowski M, et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 2012;8:51-9.
12. Alexopoulos P, Sorg C, Forschler A, et al. Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI. Eur Arch Psychiatry Clin Neurosci 2012;262:69-77.
13. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100.
14. Dai W, Lopez OL, Carmichael OT, et al. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856-66.
15. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-9.
16. Binnewijzend MA, Kuijer JP, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267:221-30.
17. Koedam EL, Lauffer V, van der Vlies AE, et al. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis 2010;19:1401-8.
18. Smits LL, Pijnenburg YA, Koedam EL, et al. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 2012;30:101-8.
19. Garre-Olmo J, Genis Batlle D, del Mar Fernandez M, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology 2010;75:1249-55.
20. Sa F, Pinto P, Cunha C, et al. Differences between early and late-onset Alzheimer's disease in neuropsychological tests. Front Neurol 2012;3:81. Retrieved May 14, 2012, from journal.frontiersin.org/article/10.3389/fneur.2012.00081/.
21. Balasa M, Gelpi E, Antonell A, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 2011;76:1720-5.
22. van Vliet D, de Vugt ME, Bakker C, et al. Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychol Med 2013;43:423-32.
23. Cavedo E, Pievani M, Boccardi M, et al. Medial temporal atrophy in early and late-onset Alzheimer's disease. Neurobiol Aging 2014;35:2004-12.
24. Frisoni GB, Pievani M, Testa C, et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007;130:720-30.
25. Frisoni GB, Testa C, Sabattoli F, et al. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry 2005;76:112-4.
26. Ishii K, Kawachi T, Sasaki H, et al. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. Am J Neuroradiol 2005;26:333-40.
27. Karas G, Scheltens P, Rombouts S, et al. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007;49:967-76.
28. Shibuya Y, Kawakatsu S, Hayashi H, et al. Comparison of entorhinal cortex atrophy between early-onset and late-onset Alzheimer's disease using the VSRAD, a specific and sensitive voxel-based morphometry. Int J Geriatr Psychiatry 2013;28:372-6.
29. Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005;128:1790-801.
30. Rabinovici GD, Furst AJ, Alkalay A, et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010;133:512-28.
31. Mosconi L, Sorbi S, de Leon MJ, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47:1778-86.
32. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-9.
33. Wang J, Alsop DC, Song HK, et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003;50:599-607.
34. Fischl B, Sereno MI, Tootell RB, et al. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999;8:272-84.
35. Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009;48:63-72.
36. Dukart J, Mueller K, Horstmann A, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage 2010;49:1490-5.
37. Maumet C, Maurel P, Ferre JC, et al. Patient-specific detection of perfusion abnormalities combining within-subject and between-subject variances in Arterial Spin Labeling. Neuroimage 2013;81:121-30.
38. Casanova R, Srikanth R, Baer A, et al. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007;34:137-43.
39. Herholz K, Schopphoff H, Schmidt M, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. J Nucl Med 2002;43:21-6.
40. Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102-16.
41. Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358-65.
42. Raji CA, Lee C, Lopez OL, et al. Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. Am J Neuroradiol 2010;31:847-55.
43. Kushner M, Tobin M, Alavi A, et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 1987;28:1667-70.
44. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895.
45. Ishii K, Willoch F, Minoshima S, et al. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001;42:548-57.
46. Vlassenko AG, Vaishnavi SN, Couture L, et al. Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc Natl Acad Sci U S A 2010;107:17763-7.
47. Kilroy E, Apostolova L, Liu C, et al. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15o-water positron emission tomography. J Magn Reson Imaging 2013;39:931-9.